학술논문
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
Document Type
Article
Author
Shah, M.; Lingam, H.; Gao, X.; Gittleman, H.; Fiero, M.H.; Krol, D.; Biel, N.; Ricks, T.K.; Fu, W.; Hamed, S.; Li, F.; Sun, J.; Fan, J.; Schuck, R.; Grimstein, M.; Tilley, A.; Tang, S.; Pazdur, R.; Kluetz, P.; Amiri-Kordestani, L.; Tang, L.; Kalavar, S.; Abukhdeir, A.; Pathak, A.; Ghosh, S.; Bulatao, I.; Pierce, W.F.; Mixter, B.D.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 1 April 2024, 42(10):1193-1201)
Subject
Language
English
ISSN
15277755
0732183X
0732183X